A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human oocytes: a retrospective cohort study

Journal of Assisted Reproduction and Genetics

Volumn 33, Issue 3, 2016, Pages 413-421

  Coello, Aila ^a   Campos, Pilar ^a   Remohí, José ^a   Meseguer, Marcos ^a   Cobo, Ana ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Clinical outcome; Hydroxypropyl cellulose; Macromolecular supplement; Oocyte vitrification; Survival rate

Indexed keywords

HYDROXYPROPYLCELLULOSE; SERUM SUBSTITUTE SUPPLEMENT; SUCROSE; TREHALOSE; UNCLASSIFIED DRUG; CELLULOSE; CULTURE MEDIUM;

ADULT; ARTICLE; BLASTOCYST; COHORT ANALYSIS; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE DONATION; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; SUPPLEMENTATION; SURVIVAL RATE; VITRIFICATION; VITRIFICATION DEVICE; WARMING; YOUNG ADULT; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; CULTURE MEDIUM; CYTOLOGY; IN VITRO FERTILIZATION; LIVE BIRTH; OVULATION INDUCTION; PHYSIOLOGY; PREGNANCY; PROCEDURES; TREATMENT OUTCOME;

BLASTOCYST; CASE-CONTROL STUDIES; CELLULOSE; COHORT STUDIES; CULTURE MEDIA; FEMALE; FERTILIZATION IN VITRO; HUMANS; LIVE BIRTH; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TREHALOSE; VITRIFICATION;

EID: 84960359145     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-015-0633-9     Document Type: Article

References (49)

1. Cobo A, Kuwayama M, Perez S, Ruiz A, Pellicer A, Remohi J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2008;89:1657–64.
2. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod. 2010;25:66–73.
3. Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25:2239–46.
4. Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011;23:323–33.
5. Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10:268–73.
6. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod. 2011;26:655–61.
7. Cobo A, Garrido N, Crespo J, Jose R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online. 2012;24:424–32.
8. Song WY, Sun YP, Jin HX, Xin ZM, Su YC, Chian RC. Clinical outcome of emergency egg vitrification for women when sperm extraction from the testicular tissues of the male partner is not successful. Syst Biol Reprod Med. 2011;57:210–3.
9. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vajta G. The efficacy and safety of human oocyte vitrification. Semin Reprod Med. 2009;27:450–5.
10. Herrero L, Pareja S, Losada C, Cobo AC, Pellicer A, Garcia-Velasco JA. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril. 2011;95:1137–40.
11. Seki S, Mazur P. Ultra-rapid warming yields high survival of mouse oocytes cooled to −196 degrees c in dilutions of a standard vitrification solution. PLoS One. 2012;7:e36058.
12. Rall WF, Fahy GM. Ice-free cryopreservation of mouse embryos at −196 degrees C by vitrification. Nature. 1985;313:573–5.
13. Weathersbee PS, Pool TB, Ord T. Synthetic serum substitute (SSS): a globulin-enriched protein supplement for human embryo culture. J Assist Reprod Genet. 1995;12:354–60.
14. Inoue F. Hydroxypropyl cellulose as a macromolecular supplement for cryopreservation of bovine oocytes and blastocysts and human oocytes. Low Temp Med. 2012;38.
15. Strom AR, Kaasen I. Trehalose metabolism in Escherichia coli: stress protection and stress regulation of gene expression. Mol Microbiol. 1993;8:205–10.
16. Behm CA. The role of trehalose in the physiology of nematodes. Int J Parasitol. 1997;27:215–29.
17. Hengherr S, Heyer AG, Kohler HR, Schill RO. Trehalose and anhydrobiosis in tardigrades—evidence for divergence in responses to dehydration. FEBS J. 2008;275:281–8.
18. Vanin S, Bubacco L, Beltramini M. Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. Cryo Lett. 2008;29:485–91.
19. Weber AP, Horst RJ, Barbier GG, Oesterhelt C. Metabolism and metabolomics of eukaryotes living under extreme conditions. Int Rev Cytol. 2007;256:1–34.
20. McWilliams RB, Gibbons WE, Leibo SP. Osmotic and physiological responses of mouse zygotes and human oocytes to mono- and disaccharides. Hum Reprod. 1995;10:1163–71.
21. Eroglu A, Bailey SE, Toner M, Toth TL. Successful cryopreservation of mouse oocytes by using low concentrations of trehalose and dimethylsulfoxide. Biol Reprod. 2009;80:70–8.
22. Honadel TE, Killian GJ. Cryopreservation of murine embryos with trehalose and glycerol. Cryobiology. 1988;25:331–7.
23. Zhang XB, Li K, Yau KH, Tsang KS, Fok TF, Li CK, et al. Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long-term culture-initiating cells, and nonobese diabetic-SCID repopulating cells. Transfusion. 2003;43:265–72.
24. Bellver J, Ayllon Y, Ferrando M, Melo M, Goyri E, Pellicer A, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93:447–54.
25. Soares SR, Troncoso C, Bosch E, Serra V, Simon C, Remohi J, et al. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab. 2005;90:4399–404.
26. Ardoy M, Calderón G, Arroyo G, Cuadros J, Figueroa M, Herrer R. ASEBIR criteria for the morphological evaluation of human oocytes, early embryos and blastocysts. ASEBIR clinical embryology papers. 2008.
27. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270–83.
28. Gardner DKSW. In vitro culture of human blastocysts. In: Jansen R, Mortimer D, editors. Toward reproductive certainty: infertility and genetics beyond 1999. Carnforth: Parthenon Press; 1999.
29. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009;92:1520–4.
30. Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P, et al. Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod. 2002;17:671–94.
31. Laverge H, De Sutter P, Desmet R, Van der Elst J, Dhont M. Prospective randomized study comparing human serum albumin with fetal cord serum as protein supplement in culture medium for in-vitro fertilization. Hum Reprod. 1997;12:2263–6.
32. Caro CM, Trounson A. Successful fertilization, embryo development, and pregnancy in human in vitro fertilization (IVF) using a chemically defined culture medium containing no protein. J In Vitro Fert Embryo Transf. 1986;3:215–7.
33. Kruger TF, Stander FS, Smith K, Van der Merwe JP, Lombard CJ. The effect of serum supplementation on the cleavage of human embryos. J In Vitro Fert Embryo Transf. 1987;4:10–2.
34. Ogawa T, Marrs RP. The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril. 1987;47:156–61.
35. Isobe T, Ikebata Y, Onitsuka T, Do LT, Sato Y, Taniguchi M, et al. Cryopreservation for bovine embryos in serum-free freezing medium containing silk protein sericin. Cryobiology. 2013;67:184–7.
36. Alberda AT, van Os HC, Zeilmaker GH, Rothbarth PH, Heijtink RA, Schalm SW. Hepatitis B virus infection in women treated with in-vitro fertilization. Ned Tijdschr Geneeskd. 1989;133:20–5.
37. Gardner DK. Mammalian embryo culture in the absence of serum or somatic cell support. Cell Biol Int. 1994;18:1163–79.
38. Menezo Y, Testart J, Perrone D. Serum is not necessary in human in vitro fertilization, early embryo culture, and transfer. Fertil Steril. 1984;42:750–5.
39. Adler A, Reing AM, Bedford JM, Alikani M, Cohen J. Plasmanate as a medium supplement for in vitro fertilization. J Assist Reprod Genet. 1993;10:67–71.
40. Pool TB, Martin JE. High continuing pregnancy rates after in vitro fertilization-embryo transfer using medium supplemented with a plasma protein fraction containing alpha- and beta-globulins. Fertil Steril. 1994;61:714–9.
41. Desai NN, Sheean LA, Martin D, Gindlesperger V, Austin CM, Lisbonna H, et al. Clinical experience with synthetic serum substitute as a protein supplement in IVF culture media: a retrospective study. J Assist Reprod Genet. 1996;13:23–31.
42. Meintjes M, Chantilis SJ, Ward DC, Douglas JD, Rodriguez AJ, Guerami AR, et al. A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. Hum Reprod. 2009;24:782–9.
43. Kasai M, Komi JH, Takakamo A, Tsudera H, Sakurai T, Machida T. A simple method for mouse embryo cryopreservation in a low toxicity vitrification solution, without appreciable loss of viability. J Reprod Fertil. 1990;89:91–7.
44. Skaer HB, Franks F, Asquith MH, Echlin P. Polymeric cryoprotectants in the preservation of biological ultrastructure. III. Morphological aspects. J Microsc. 1977;110:257–70.
45. Gardner DK, Rodriegez-Martinez H, Lane M. Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. Hum Reprod. 1999;14:2575–80.
46. Bungum M, Humaidan P, Bungum L. Recombinant human albumin as protein source in culture media used for IVF: a prospective randomized study. Reprod Biomed Online. 2002;4:233–6.
47. Kuwayama M. Efficiency of non-protein solutions using hydroxypropyl cellulose on survival of bovine and human oocytes and embryos after vitrification. Fertil Steril. 2013;10:S174.
48. Mori C, Yabuuchi A, Ezoe K, Murata N, Takayama Y, Okimura T, et al. Hydroxypropyl cellulose as an option for supplementation of cryoprotectant solutions for embryo vitrification in human assisted reproductive technologies. Reprod Biomed Online. 2015;30:613–21.
49. Golovina EA, Golovin AV, Hoekstra FA, Faller R. Water replacement hypothesis in atomic detail—factors determining the structure of dehydrated bilayer stacks. Biophys J. 2009;97:490–9.